3 Biotech companies backed by Sofinnova Investments, including Seaport Therapeutics, ARTBIO, Atsena Therapeutics — with the co-investors on each cap table.
Sofinnova Investments — Biotech accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $2.2B. The median disclosed raise is $190M, and the largest is Avenzo Therapeutics at $446M, ahead of Seaport Therapeutics ($330M) and BIOAGE LABS ($300M).
The names that recur most often on these portfolio cap tables are Sofinnova Investments (10 companies), OrbiMed (3 companies), Third Rock Ventures (3 companies), Foresite Capital (2 companies), F-Prime Capital (2 companies), Omega Funds (2 companies). By latest disclosed round, the market skews Series A (4), Series D (3), Series B (2).